NASDAQ · BCYP
Big Cypress Acquisition Corp.
Healthcare · Biotechnology
$8.44
Down-$2.01 (-19.23%)
Updated Aug 16, 2026, 10:03 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 425.36M
- P/E ratio
- 2.99
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 15.34M
- Avg. volume
- 2.27M
Price performance
BCYP price history
1M range · 0 trading sessions · Daily adjusted prices
BCYP does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest BCYP news
The latest Smart Investors Daily articles mentioning BCYP.
Stock researchCompany · Overview
BCYP research
Overview
Company profile and research snapshot.
Company profile
Big Cypress Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It intends to focus on life science companies in the United States and Israel. The company was founded in 2020 and is based in Miami Beach, Florida.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $17.60
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 4, 2021 | Northland Capital Markets | Outperform | — |
| Oct 1, 2021 | Ladenburg Thalmann | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
